4
Changes in Ownership
Cadrenal Therapeutics, Inc. Filed Acc 0001213900-23-004882
Director acquired 514,792 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
MURPHY JOHN RAYMOND · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-24 | Conversion : show line 1 in the form | +514,792 | 554,792 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-24 | Conversion : show line 2 in the form Convertible Promissory Note | −514,792 | 0 | D |
Loading xslF345X03/ownership.xml…